Orlistat Vs Metformin
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anovulation
Conditions
Anovulation, Obesity
Trial Timeline
Feb 1, 2006 → Feb 1, 2008
NCT ID
NCT00292799About Orlistat Vs Metformin
Orlistat Vs Metformin is a pre-clinical stage product being developed by Roche for Anovulation. The current trial status is completed. This product is registered under clinical trial identifier NCT00292799. Target conditions include Anovulation, Obesity.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00292799 | Pre-clinical | Completed |
Competing Products
3 competing products in Anovulation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| MSJ-0011 + urinary hCG (u-hCG) + Follitropin alpha | Merck | Phase 3 | 77 |
| usual administration of exogenous recombinant FSH | Organon | Pre-clinical | 18 |
| Follitropin beta | Organon | Pre-clinical | 18 |